Open AccessA retrospective study on therapeutic drug monitoring of mood stabilizers in real-life clinical scenario
Author(s) -
Hawra Abu-Qurain,
Fatimah Almashhad,
Jisha M Lucca,
Mahdi S Abumadini
Publication year - 2020
Publication title -
journal of pharmacy and bioallied sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 36
eISSN - 0976-4879
pISSN - 0975-7406
DOI - 10.4103/jpbs.jpbs_368_19
Subject(s) - mood , medicine , therapeutic drug monitoring , mood stabilizer , retrospective cohort study , drug , mood disorders , pharmacotherapy , bipolar disorder , valproic acid , population , adverse effect , psychiatry , pediatrics , emergency medicine , environmental health , anxiety , epilepsy
Therapeutic drug monitoring (TDM) is the widely used tool in neuropsychiatric disorders. It is a valuable tool for tailoring the dose, preventing adverse drug reactions, and testing the drug adherence, therapeutic nonresponse, pharmacokinetic, and drug-drug interactions. TDM is most useful for individualized pharmacotherapy in bipolar disorders. But there exists a death of information on TDM of mood stabilizers in real-life scenario. Hence, this study aimed to assess the use and indication of TDM for mood stabilizers in a university hospital.